Abstract |
Inhibition of the interaction between the tumor suppressor protein p53 and its negative regulators MDM2 and MDMX is of great interest in cancer biology and drug design. We previously reported a potent duodecimal peptide inhibitor, termed PMI ( TSFAEYWNLLSP), of the p53-MDM2 and -MDMX interactions. PMI competes with p53 for MDM2 and MDMX binding at an affinity roughly 2 orders of magnitude higher than that of (17-28)p53 (ETFSDLWKLLPE) of the same length; both peptides adopt nearly identical alpha-helical conformations in the complexes, where the three highlighted hydrophobic residues Phe, Trp, and Leu dominate PMI or (17-28)p53 binding to MDM2 and MDMX. To elucidate the molecular determinants for PMI activity and specificity, we performed a systematic Ala scanning mutational analysis of PMI and (17-28)p53. The binding affinities for MDM2 and MDMX of a total of 35 peptides including 10 truncation analogs were quantified, affording a complete dissection of energetic contributions of individual residues of PMI and (17-28)p53 to MDM2 and MDMX association. Importantly, the N8A mutation turned PMI into the most potent dual-specific antagonist of MDM2 and MDMX reported to date, registering respective K(d) values of 490 pM and 2.4 nM. The co-crystal structure of N8A-PMI-(25-109)MDM2 was determined at 1.95 A, affirming that high-affinity peptide binding to MDM2/MDMX necessitates, in addition to optimized intermolecular interactions, enhanced helix stability or propensity contributed by non-contact residues. The powerful empirical binding data and crystal structures present a unique opportunity for computational studies of peptide inhibition of the p53-MDM2/MDMX interactions.
|
Authors | Chong Li, Marzena Pazgier, Changqing Li, Weirong Yuan, Min Liu, Gang Wei, Wei-Yue Lu, Wuyuan Lu |
Journal | Journal of molecular biology
(J Mol Biol)
Vol. 398
Issue 2
Pg. 200-13
(Apr 30 2010)
ISSN: 1089-8638 [Electronic] Netherlands |
PMID | 20226197
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Copyright | (c) 2010 Elsevier Ltd. All rights reserved. |
Chemical References |
- Cell Cycle Proteins
- MDM4 protein, human
- Nuclear Proteins
- Oligopeptides
- Proto-Oncogene Proteins
- Tumor Suppressor Protein p53
- threonyl-seryl-phenylalanyl-alanyl-glutamyl-tyrosyl-tryptophyl-asparagyl-leucyl-leucyl-seryl-proline
- MDM2 protein, human
- Proto-Oncogene Proteins c-mdm2
|
Topics |
- Amino Acid Sequence
- Binding, Competitive
- Cell Cycle Proteins
- Crystallography, X-Ray
- DNA Mutational Analysis
- Humans
- Nuclear Proteins
(antagonists & inhibitors, chemistry)
- Oligopeptides
(chemistry, genetics, pharmacology)
- Protein Conformation
- Proto-Oncogene Proteins
(antagonists & inhibitors, chemistry)
- Proto-Oncogene Proteins c-mdm2
(antagonists & inhibitors, chemistry)
- Tumor Suppressor Protein p53
(antagonists & inhibitors, chemistry, genetics)
|